Hims & Hers Health (NYSE: HIMS) stock labored mightily on Wednesday, but in the end, it couldn't top the benchmark S&P 500 ...

Telehealth platform Hims & Hers Health, Inc. (HIMS), which connects consumers to healthcare professionals, is at a crossroads ...

Hims & Hers (NYSE: HIMS) continues to grow at an astounding rate as the company grows subscribers and revenue per subscriber. But Hims & Hers stock is falling after earnings because investors are ...

The ad ignited a surge in retail chatter on Stocktwits, with Hims' sentiment trending 'extremely bullish' and the ticker ranking among the platform's top-trending symbols before the bell.

Jon and Pete Najarian join forces to discuss and debate their favorite topics, including the hottest stock-specific news and sports! Today: $CHGG, $BYND, $HIMS, and ...

(This section is what permits Hims & Hers to produce otherwise patent-protected GLP-1 drugs while the supply of such drugs is in deficit.) As regards semaglutide, FDA says compounders such as Hims ...

Bullish option flow detected in Hims and Hers Health with 78,417 calls trading, 2.0x expected, and implied vol increasing almost 3 points to 106.33%. 2/28 weekly 45 calls and 2/28 weekly 43 calls ...